Drug class
Muscarinic acetylcholine receptor antagonist; urinary antispasmodic
Mechanism of action
Fesoterodine is converted to the active metabolite 5-hydroxymethyl tolterodine, which competitively antagonises muscarinic receptors in the bladder, reducing detrusor overactivity and urinary urgency.
General use cases
- Treatment of overactive bladder in adults with symptoms of urge urinary incontinence, urgency and urinary frequency
- Treatment of neurogenic detrusor overactivity in selected paediatric patients aged 6 years and older weighing more than 25 kg under the US product indication
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
